CD40LG and melanoma: Numerous studies have, however, demonstrated that IgM antibodies provide extended tumour immunosurveillance as well as anti-tumour cytotoxic activity in other organisms4, 5, 6, 7, 8, 9, and IgM antibody therapy has been shown to reduce neuroblastoma and melanoma in humans10, 11.